Evidence map›Paper›PMID 32906824›Full record

ArticleAntibiotics (Basel, Switzerland)2020

Preventing and Managing Urinary Tract Infections: Enhancing the Role of Community Pharmacists-A Mixed Methods Study.

Nathan Peiffer-Smadja, Rosalie Allison, Leah F Jones, Alison Holmes, Parvesh Patel, Donna M Lecky, Raheelah Ahmad, Cliodna A M McNulty

Open access · goldAbstract read
In one paragraph

Article in Antibiotics (Basel, Switzerland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 1 pooled it
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 1 synthesis or guideline pooled it, 20 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. "Antibiotics (Basel, Switzerland) · 2025
    Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 2 countries.

Nathan Peiffer-SmadjaNational Institute for Health Research Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance, Faculty of Medicine, Imperial College London, The Hammersmith Hospital, Commonwealth Building, Du Cane Road, London W12 0NN, UK.
Rosalie AllisonPrimary Care and Interventions Unit, Public Health England, Gloucester GL1 1DQ, UK.ORCID 0000-0003-1266-2549
Leah F JonesPrimary Care and Interventions Unit, Public Health England, Gloucester GL1 1DQ, UK.ORCID 0000-0002-0448-3471
Alison HolmesNational Institute for Health Research Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance, Faculty of Medicine, Imperial College London, The Hammersmith Hospital, Commonwealth Building, Du Cane Road, London W12 0NN, UK.
Parvesh PatelLocal Pharmaceutical Committee, Newham, London E7 8BA, UK.
Donna M LeckyPrimary Care and Interventions Unit, Public Health England, Gloucester GL1 1DQ, UK.ORCID 0000-0002-1223-9356
Raheelah AhmadNational Institute for Health Research Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance, Faculty of Medicine, Imperial College London, The Hammersmith Hospital, Commonwealth Building, Du Cane Road, London W12 0NN, UK.
Cliodna A M McNultyPrimary Care and Interventions Unit, Public Health England, Gloucester GL1 1DQ, UK.ORCID 0000-0003-4969-5360
Public Health England · GBCity, University of London · GBHammersmith Hospital · GBRoyal Pharmaceutical Society · GBUniversité Claude Bernard Lyon 1 · FR

Funding

The research was funded by the National Institute for Health Research Health Protection Research Unit (NIHR HPRU) in Healthcare Associated Infections and Antimicrobial Resistance at Imperial College London in partnership with Public Health England (PHE), X
6 · The paper itself

Abstract

backgroundCommunity pharmacists are involved in antimicrobial stewardship through self-care advice and delivering medications for uncomplicated infections.

objectivesThis mixed methods study aimed to identify opportunities to enhance the role of community pharmacists in the management of service users with suspected or confirmed urinary tract infection (UTI).

methodsData collection was through a service user survey (n = 51) and pharmacist surveys and semi-structured interviews before (16 interviews, 22 questionnaires) and after (15 interviews, 16 questionnaires) trialing UTI leaflets designed to be shared with service users. Data were analysed inductively using thematic analysis and descriptive tabulation of quantitative data.

resultsTwenty-five percent (n = 13/51) of service users with urinary symptoms sought help from a pharmacist first and 65% (n = 33/51) were comfortable discussing their urinary symptoms with a pharmacist in a private space. Community pharmacists were confident as the first professional contact for service users with uncomplicated UTI (n = 13/16, 81%), but indicated the lack of a specific patient referral pathway (n = 16/16, 100%), the need for additional funding and staff (n = 10/16, 62%), and the importance of developing prescription options for pharmacists (5/16, 31%). All community pharmacists reported playing a daily role in controlling antimicrobial resistance by educating service users about viral and bacterial infections and promoting a healthy lifestyle. Enhancing their role will need greater integrated working with general practices and more prescribers based in community pharmacy.

conclusionThis study suggests that community pharmacists could play a greater role in the management of uncomplicated UTI. The current reconfiguration of primary care in England with primary care networks and integrated care systems could provide a real opportunity for this collaborative working with potential learning for international initiatives.

Indexed as

communitygeneral publicleafletpharmacistself-careurinary tract infections

Identifiers

PMID32906824
PMCPMC7559416
OpenAlexW3043419955

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.